quotable quotes - October 2013
“In all the work with diabetes technology I’ve done, I’ve worn CGM for long periods of time. I don’t have diabetes, but I’ll eat a dessert and go up to 200 mg/dl. I’ll also drop down to 50 or 60 mg/dl. People with diabetes are comparing themselves to a false standard. The pancreas, for all of the advantages it has, still allows big excursions. It’s crazy to think it’s ideal.”
-Dr. Steven Russell (Massachusetts General Hospital, Boston, MA) urging people with diabetes not to be too hard on themselves at the 14th North American Conference on Diabetes and Exercise in San Diego, CA, August 17-18.
“Try to keep something on the schedule – physical activity, a race on your calendar, something to continue to pursue. You might not make that race, but at least you have something to shoot for. Exercise is such a key component to control. You must have the guts to try it and do some crazy things… For the newly diagnosed, my advice to you is to listen, listen, listen, and learn and try to get as many tools as you can.”
-Ironman legend Bill Carlson on what helped him succeed with diabetes over the years at the 14th North American Conference on Diabetes and Exercise.
“The final bullet of my final slide said, ‘The time to create the BGMSP (Blood Glucose Monitor Surveillance Program) is now.’ Movements have a time. Ideas have a time. I believe that the time for this movement is now… What I plan to do is get a sense of what the diabetes community thinks.”
-Dr. David Klonoff (University of California at San Francisco, San Francisco, CA) on the Diabetes Technology Society’s (DTS) proposed post-market blood glucose surveillance program at the Diabetes Technology Society meeting. For more information about the DTS meeting, please read our new now next in this issue.
“[The] FDA is very interested in a credible surveillance program. We are willing to work with DTS to provide insight into what would make it credible.”
-Dr. Courtney Lias (FDA, Silver Spring, MD) on the DTS proposed post-market blood glucose surveillance program at the Diabetes Technology Society meeting.
“Diabetes itself is very silent. The management is very loud.”
-A person with diabetes at the Abbott symposium at the 2013 European Association for the Study of Diabetes (EASD) Meeting in Barcelona, Spain, September 23-27.
